89 related articles for article (PubMed ID: 20732753)
1. Role of peroxiredoxin I in rectal cancer and related to p53 status.
Chen MF; Lee KD; Yeh CH; Chen WC; Huang WS; Chin CC; Lin PY; Wang JY
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):868-78. PubMed ID: 20732753
[TBL] [Abstract][Full Text] [Related]
2. p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment.
Chen MF; Chen WC; Wu CT; Lin PY; Shau H; Liao SK; Yang CT; Lee KD
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1461-72. PubMed ID: 17084559
[TBL] [Abstract][Full Text] [Related]
3. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression.
Chen MF; Keng PC; Shau H; Wu CT; Hu YC; Liao SK; Chen WC
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):581-91. PubMed ID: 16414373
[TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
[TBL] [Abstract][Full Text] [Related]
8. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma.
Nehls O; Klump B; Holzmann K; Lammering G; Borchard F; Gruenagel HH; Gaco V; Gregor M; Porschen R
Cancer; 1999 Jun; 85(12):2541-8. PubMed ID: 10375100
[TBL] [Abstract][Full Text] [Related]
9. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
[TBL] [Abstract][Full Text] [Related]
10. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
11. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
13. p53 and DCC immunohistochemistry in curative rectal cancer surgery.
Morgan M; Koorey D; Painter D; Findlay M; Newland R; Chapuis P; Solomon M
Int J Colorectal Dis; 2003 May; 18(3):188-95. PubMed ID: 12673482
[TBL] [Abstract][Full Text] [Related]
14. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
15. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
16. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers and prediction of response to chemoradiation in rectal cancer.
Okonkwo A; Musunuri S; Talamonti M; Benson A; Small W; Stryker SJ; Rao MS
Oncol Rep; 2001; 8(3):497-500. PubMed ID: 11295069
[TBL] [Abstract][Full Text] [Related]
18. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
19. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
[TBL] [Abstract][Full Text] [Related]
20. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
